Could seizures trigger hidden psychotic symptoms? new study investigates
NCT ID NCT07471334
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will track 110 people with drug-resistant focal epilepsy during a hospital stay to see how often they develop mild psychotic symptoms after seizures. Researchers will use psychiatric interviews and questionnaires at three time points. The goal is to better understand these symptoms and find ways to identify them early.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If this study succeeds, it could help doctors spot early warning signs of post-seizure psychosis and develop ways to prevent it.
- What could go wrong
- This is an early observational study with only 110 people, so results may not apply to everyone. It is not testing a treatment, so it won't directly change care yet.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 110 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * confirmed diagnosis of drug-resistant focal epilepsy * hospitalization for at least 5 days video-EEG (or SEEG) monitoring * capable of providing informed consent, able to communicate in French, and covered by a national health insurance plan Exclusion Criteria: * Patients presenting with psychotic symptoms at baseline (V1), or who have had recent modifications (less than 15 days before admission) to their antiepileptic or psychotropic medications, will be excluded to reduce confounding factors in the assessment of postictal psychotic symptoms.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Focal epilepsy with and without secondary generalization are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.